Klow Blend is a composite vial containing four well-characterised synthetic peptides under investigation for distinct yet complementary biochemical pathways: GHK-Cu (copper-binding tripeptide), BPC-157 (Body Protection Compound-157), TB-4 (Thymosin Beta-4 fragment), and KPV (Lys-Pro-Val tripeptide). Current in-vitro studies examine each component’s influence on cytoskeletal dynamics, angiogenic signalling, inflammatory-response markers and tissue-remodelling processes within wound-healing and regenerative research models.